oa Endomyocardial fibrosis: A form of endemic restrictive cardiomyopathy

References

1. Denfield SW and Webber SA.  Restrictive cardiomyopathy in childhood. Heart Fail Clin. 2010; 6::4, 445–452.
   [Google Scholar]
2. Somers K.  Restrictive Cardiomyopathies. Pongpanich B. , Sueblinvong V. and Vongprateep C.  (eds), Pediatric Cardiology. International Congress Series 906. Excerpta Medica. , Amsterdam. 1990.
   [Google Scholar]
3. Sliwa K, Damasceno A and Mayosi BM.  Epidemiology and Etiology of Cardiomyopathy in Africa. Circulation. 2005; 112::3577–3583.
   [Google Scholar]
4. Jaiyesimi F.  The aetiopathogenesis of endomyocardial fibrosis: problems and promises. Tropical Cardiology. 1980; 6::23, 113–120.
   [Google Scholar]
5. Freers J, Mayanga-Kizza H, Ziegler JJ and Rutakingirwa M.  Echocardiographic diagnosis of heart disease in Uganda. Tropical Doctor. 1996; 26::125–128.
   [Google Scholar]
6. Mayanga-Kizza H, Gerwing E, Rutakingirwa M, Mugerwa R and Freers J.  Tropical endomyocardial fibrosis in Uganda: the tribal and geographic distribution, and the association with eosinophilia. Tropical Cardiology. 2000; 26::103, 45–48.
   [Google Scholar]
7. Rutakingirwa M, Ziegler JL, Newton R and Freers J.  Poverty and eosinophilia are risk factors endomyocardial fibrosis (EMF) in Uganda. Trop Med Inter Health. 1999; 4::3, 229–235.
   [Google Scholar]
8. Sezi C.  Effect of protein deficient cassava diet on cercopithecus aethiops hearts and its possible role in the aetiology and pathogenesis of endomyocardial fibrosis in man. East African Medical Journal. 1996;S11–S16.
   [Google Scholar]
9. Sezi C.  Effects of cassava diet on cercopithecus Aethiops Livers: a case for cassavas the cause of both tropical splenomegaly syndrome (tss) and endomyocardial fibrosis (EMF). East African Medical Journal. 1996;S24–S28.
   [Google Scholar]
10. Davies H.  Endomyocardial fibrosis and the tuberous diet. Int J Cardiol. 1990; 29::3–8.
    [Google Scholar]
11. Ojo GO.  The pathogenesis of endomyocardial fibrosis: the question of 5-hydroxytriptamine. Brit Heart J. 1970; 32::671–674.
    [Google Scholar]
12. Mckinney B.  Studies on the experimental production of endomyocardial fibrosis and cardiomegaly of unknown origin by dietary means. Am Heart J. 1975; 90::2, 206–214.
    [Google Scholar]
13. Kartha CC, Valiathan MS, Eapen JT, Rathinam K, Kumary TV and Kutty VR.  Enhancement of cerium levels and associated myocardial lesions in hypomagnesaemic rats fed on cerium-adulterated diet. Somers K. and Kartha CC.  (eds), Endomyocardial Fibrosis Valiathan MS. Oxfrd University Press. , Dehli. 1993. 243–253.
    [Google Scholar]
14. Patel AK, D’Arbela PG and Somers K..  Endomyocardial Fibrosis and eosinophilia. British Heart Journal. 1977; 39::238–241.
    [Google Scholar]
15. Bukhman G, Ziegler J and Parry E.  Endomyocardial Fibrosis: Still a Mystery after 60 Years. PLoS Negl Trop Dis. 2008; 2::2, e97. [CrossRef]
    https://doi.org/10.1371/journal.pntd.0000097 [Google Scholar]
16. Beck W and Schrire V.  Endomyocardial fibrosis in Caucasians previously resident in tropical Africa. Brit Heart J. 1972; 34::915–918.
    [Google Scholar]
17. Brockington IF, Olsen EGJ and Goodwin JF.  Endomyocardial Fibrosis in Europeans resident in Africa. Lancet. 1967; 289::7490, 583–588.
    [Google Scholar]
18. Eling WMC, Jerusalem CR, Heinen-Borries UJ, Hermsen CC and Run-van Breda JJ.  Is malaria involved in the pathogenesis of tropical endomyocardial fibrosis?. Acta Leidensia. 1988; 1::47–52.
    [Google Scholar]
19. Elling WM, Henein-Borris U, Van Run-Van Breda JJ and Jerusalem CR.  Activated macrophages : inductors of endocardial lesions in murine malaria. Cell Biol Int Rep. 1983; 7::5, 321.
    [Google Scholar]
20. Victor EG, Lira V, Arruda A, Monteiro I and Lima R.  Granulomas cardiacos a ovos de schistosoma e fibrose endomiocardica. Arq Bras Cardiol. 1996; 67::4, 259–261.
    [Google Scholar]
21. Berenguer A, Plancha E and Gil JM.  Right ventricular endomyocardial fibrosis and microfilarial infection. Int J Card. 2003; 87::287–289.
    [Google Scholar]
22. Andy JJ and Bishara FF.  Soyinka OO. Relation of severe eosinophilia and microfilariasis to chronic African endomyocardial fibrosis. Br Heart Journal. 1981; 45::672–680.
    [Google Scholar]
23. Andy JJ, Ogunowo PO, Akpan NA, Odigwe CO, Ekanem IA and Esin RA.  Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria. Acta Tropica. 1998; 69::2, 127–140.
    [Google Scholar]
24. Andy JJ.  Helminthiasis, the hypereosinophilic syndrome and endomyocardial fibrosis: some observations and an hypothesis. Afr J Med Sci. 1983; 12::3–4, 155–164.
    [Google Scholar]
25. Ijaola O and Falase AO.  The aetiology of endomyocardial fibrosis (EMF): Eosinophilia and parasitic infestations in EMF patients and normal subjects from EMF endemic and non-endemic zones of Nigeria. Tropical Cardiology. 1988; 14::53, 17–23.
    [Google Scholar]
26. Ijaola O and Falase AO.  Distribution of antibodies against Coxsackie B viruses, arboviruses and toxoplasma gondii among patients with endomyocardial fibrosis (EMF) compared with normal subjects from EMF endemic and non-endemic zones of Nigeria. Afr J Med med Sci. 1990; 19::93–103.
    [Google Scholar]
27. Ludlam GB and Somers K.  Incidence of toxoplasma antibodies in Ugandans with special reference to cardiomyopathy. Trans Royal Soc Trop Med Hyg. 1966; 60::5, 621–625.
    [Google Scholar]
28. Patel AK, Ziegler JL, D’Arbela PG and Somers K.  Familial Cases of Endomyocardial Fibrosis in Uganda. British Medical Journal. 1971; 4::331–334.
    [Google Scholar]
29. Lowenthal MN.  Endomyocardial Fibrosis: familial and other cases from Zambia. Medical Journal of Zambia. 1978; 12::1, 2–7.
    [Google Scholar]
30. Mocumbi AO, Ferreira MB, Sidi D and Yacoub MH.  A population study of Endomyocardial Fibrosis in a rural area of Mozambique. N Eng J Med. 2008; 369::43–49.
    [Google Scholar]
31. Shaper AG, Kaplan MH, Mody NJ and McIntyre PA.  Malarial Antibodies and Autoanti-bodies to Heart and other tissues in the immigrant and indigenous peoples of Uganda. Lancet. 1968; 291::7556, 1342–1347.
    [Google Scholar]
32. van der Geld H, Peetoom F, Somers K and Kanyerezi BR.  Immunohistological and serological studies in endomyocardial fibrosis. Lancet. 1966; 2::7475, 1210–1213.
    [Google Scholar]
33. Mocumbi AO, Latif N and Yacoub MH.  Presence of circulating anti-myosin antibodies in endomyocardial fibrosis. PLoS Negl Trop Dis. 2010; 4::4, e-661.
    [Google Scholar]
34. Kartha CC, Mathai A, Balakrishnan KG and Valiathan MS.  Immunohistological studies in endomyocardial fibrosis. Indian Heart Journal. 1984; 36::2, 90–91.
    [Google Scholar]
35. Mathai A, Kartha CC and Balakrishnan KG.  Serum immunoglobulins in patients with endomyocardial fibrosis. Indian Heart Journal. 1986; 38::6, 470–472.
    [Google Scholar]
36. Connor DH, Somers K, Hutt NSR, Manion WC and D’Arbela PGD.  Endomyocardial fibrosis in Uganda (Davies’disease). Part I. Am Heart J. 1967; 74::5, 687–709.
    [Google Scholar]
37. Davies J, Spry CJ, Vijayaraghavan G and de Souza JA.  A comparison of the clinical and cardiological features of endomyocardial disease in temperate and tropical regions. Postgrad Med J. 1983; 59::179–185.
    [Google Scholar]
38. Falase AO.  Endomyocardial fibrosis in Africa. Postgrad Med J. 1983; 59::170–178.
    [Google Scholar]
39. Ferreira B, Matsika-Claquin MD, Hausse-Mocumbi AO, Sidi D and Paquet C.  Geographic origin of endomyocardial fibrosis treated at the central hospital of Maputo (Mozambique) between 1987 and 1999. Bull Soc Pathol Exot. 2002; 95::276–279.
    [Google Scholar]
40. Somers K, Gunstone RF, Patel AK and D’Arbela .  Atrial arrhythmias in Endomyocardial Fibrosis. Cardiology. 1972; 57::369–373.
    [Google Scholar]
41. Ogbogu P, Rosing DR and Horne MK.  Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007; 27::3, 457–475.
    [Google Scholar]
42. Brockington IF and Olsen EGJ.  Loeffler endocarditis and Davies’endomyocardial fibrosis. Am Heart J. 1973; 85::3, 308–322.
    [Google Scholar]
43. Patel AK, D’Arbela PG and Somers K.  Endomyocardial Fibrosis and eosinophilia. British Heart Journal. 1977; 39::238–241.
    [Google Scholar]
44. Somers K, Hutt MSR, Patel AK and D’Arbela PGD.  Endomyocardial biopsy diagnosis of cardiomyopathies. British Medical Journal. 1971; 33::822–832.
    [Google Scholar]
45. Connor DH, Somers K, Hutt NSR, Manion WC and D’Arbela P.  Endomyocardial fibrosis in Uganda (Davies’disease). Part II. Am Heart J. 1968; 74::5, 107–124.
    [Google Scholar]
46. Urhoghide GE and Falase AO.  Degranulated eosinophils, eosinophil granule basic proteins and humoral factors in Nigerians with endomyocardial fibrosis. Afr J Med med Sci. 1987; 16::133–139.
    [Google Scholar]
47. Ikeme AC.  The Diagnosis of Endomyocardial Fibrosis. Afr J med Sci. 1972; 3::327–333.
    [Google Scholar]
48. Salemi VMC, Rochitte CE, Barbosa MM and Mady C.  Clinical and echocardiographic dissociation in a patient with right ventricular endomyocardial fibrosis. Heart. 2005; 91::11, 1399.
    [Google Scholar]
49. Somers K, Patel AK and D’Arbela PG.  The natural History of African Endomyocardial Fibrosis. Hayase S. and Murao S.  (eds), 1978 Proceedings of the VIII World Congress of Cardiology. Excerpta Medica. , Holland.
    [Google Scholar]
50. Jaiyesimi F and Falase AO.  Extracardiac manifestations of endomyocardial fibrosis and their psycolosocial complications. Tropical Cardiology. 1976; 2::5, 5–11.
    [Google Scholar]
51. Iglezias SA, Benvenuti LA, Calabrese F, Salemi VMC, Silva AMG, Carturan E, Oliveira SA, Thiene G and Brito T.  Endomyocardial fibrosis: pathological and molecular findings of surgically resected ventricular endomyocardium. Virchows Arch. 2008; 453::233–241.
    [Google Scholar]
52. Mocumbi AO, Carrilho C, Sarathchandra P, Ferreira MB, Yacoub M and Burke M.  Echocardiography accurately assesses the pathological abnormalities of chronic endomyocardial fibrosis. Int J Cardiovasc Imaging. 2011 Oct; 27::7, 955–964.
    [Google Scholar]
53. Chopra P, Narula J, Talwar KK, Kumar V and Bhatia ML.  Histomorphologic characteristics of endomyocardial fibrosis: an endomyocardial biopsy study. Human Pathology. 1990; 21::6, 613–616.
    [Google Scholar]
54. Andrade ZA and Teixeira ARL.  Changes in the vasculature in endomyocardial fibrosis and their possible significance. Am Heart J. 1973; 86::152–158.
    [Google Scholar]
55. Santos CL, Moraes CR, Santos FL, Moraes F and Brindeiro Filho D.  Endomyocardial fibrosis in children. Cardiol Young. 2001; 11::2, 205–209.
    [Google Scholar]
56. Saraiva LR, Carneiro RW, Arruda MB, Brindeiro D and Lira V.  Mitral valve disease with rheumatic appearance in the presence of left ventricular endomyocardial fibrosis. Arq Bras Cardiol. 1999; 72::3, 330–332.
    [Google Scholar]
57. Bolarin DM and Andy J.  Clinical feminization and serum testosterone levels in male patients with chronic African endomyocardial fibrosis. Trop geogr Med. 1982;309–312.
    [Google Scholar]
58. Fernàndez Vàzquez E, Lacarcel Bautista C, Alcazar Navarrete B, Casado Moreno I, Espejo Guerrero A and Ruiz Carazo E.  Chronic Thromboembolic pulmonary hypertension Associated with Endomyocardial Fibrosis of the Rigth Ventricle. Arch Bronconeumol. 2003; 39::8, 370–372.
    [Google Scholar]
59. Ribeiro PA, Muthusami R and Duran CMG.  Right-sided endomyocardial fibrosis with recurrent pulmonary emboli leading to irreversible pulmonary hypertension. Br Heart J. 1992; 68::328–329.
    [Google Scholar]
60. Jaiyesimi F.  Controversies and Advances in Endomyocardial Fibrosis: A Review. Afr J Med med Sci. 1982; 11::37–46.
    [Google Scholar]
61. Freers J, Masembe V, Schmauz R and Mayanja-Kizza H.  Endomyocardial fibrosis syndrome in Uganda. Lancet. 2000; 355::1994–1995.
    [Google Scholar]
62. Jaiyesimi F, Akinyemi OO and Falase AO.  Arterial oxygen desaturation in right endomyocardial fibrosis. Afr J Med med Sci. 1977; 6::159–163.
    [Google Scholar]
63. Mady C, Salemi VMC, Ianni BM, Fernandes F and Arteaga E.  Relation Between Left Atrial Dimension and Exercise Capacity in Endomyocardial Fibrosis. Arq Bras Cardiol. 2005; 84::3, 222–224.
    [Google Scholar]
64. Zabsonre P, Renambot J, Adoh-Adoh M, N’Dori R, Coulibaly AO and Bertrand E.  Conduction disorders in chronic parietal endocarditis or endomyocardial fibrosis. 170 cases at the Cardiology Institute of Abidjan. Dakar Med. 2000; 45::1, 15–19.
    [Google Scholar]
65. Somers K, Gunstone RF, Patel AK and D’Arbela .  Atrial arrhythmias in Endomyocardial Fibrosis. Cardiology. 1972; 57::369–373.
    [Google Scholar]
66. Venkitachalam CG, Balakishnan KG and Tharakan JM.  Echocardiographic findings in endomyocardial fibrosis. Valiathan MS. , Somers K. and Kartha CC.  (eds), Endomyocardial Fibrosis. Oxfrd University Press. , Dehli. 1993. 153–167.
    [Google Scholar]
67. Hassan W, Fawzy ME, Helaly SA, Hegazy H and Malik S.  Pitfalls in Diagnosis and Clinical, Echocardiographic, and Hemodynamic Findings in Endomyocardial Fibrosis*: a 25-year experience. Chest. 2005; 128::3985–3992.
    [Google Scholar]
68. Vijayaraghavan G and Sadanandan S.  Immunological phenomena in tropical endomyocardial fibrosis. Indian Heart Journal. 1984; 36::2, 87–88.
    [Google Scholar]
69. Cherian G, Vijayaraghavan G, Krishnaswami S, Sukumar IP, John MS, Jairaj PS and Bhaktaviziam A.  Endomyocardial Fibrosis: report on the hemodynamic data in 29 patients and review of results of surgery. Am Heart J. 1982; 105::4, 659–666.
    [Google Scholar]
70. Rashwan MA, Ayman M, Ashour S, Hassanin MM and Zeina AA.  Endomyocardial fibrosis in Egypt: an illustrated review. Br Heart J. 1995; 73::284–289.
    [Google Scholar]
71. Berensztein CS, Pinero G and Marcotegui M  et al.  Usefulness of echocardiography and Doppler echocardiographiy in endomyocardial fibrosis. J Am Soc Echocardiog. 2000; 13::3, 226–230.
    [Google Scholar]
72. Mousseaux E, Hernigou A, Azencot M, Sapoval M, Auguste M, papo T, Chauvaud S and Gaux JC.  Endomyocardial Fibrosis: Electron-beam CT features. Radiology. 1996; 198::3, 755–760.
    [Google Scholar]
73. Estornell J, Lopez MP, Dicenta F, Igual B, Martinez V and Sonlleva A.  Usefulness of Magnetic Resonance Imaging in the Assessment of Endomyocardial Disease. Rev Esp Cardiol. 2003; 56::321–324.
    [Google Scholar]
74. Cury R, Abbara S, Sandoval LJ, Houser S, Brady T and Palacios IF.  Visualization of Endomyocardial Fibrosis by Delayed-Enhancement Magnetic Resonance. Imaging Circulation. 2005; 111::9, e115-117.
    [Google Scholar]
75. Smedema JP, Winckels SKG, Snoep G, Vainer J, Bekkers SCAM and Crijns HJGM.  Tropical endomyocardial fibrosis (Davies‘ disease): case report demonstrating the role of magnetic resonance imaging. Int J Cardiovasc Imaging. 2004; 20::517–522.
    [Google Scholar]
76. Salemi VM, Rochitte CE, Shiozaki AA, Andrade JM, Parga JR, de Avila LF, Benvenuti LA, Cestari IN, Picard MH, Kim RJ and Mady C.  Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients. Circ Cardiovasc Imaging. 2011;Epub ahead of print .
    [Google Scholar]
77. Falase AO, Kolawole TM and Lagundoye SB.  Endomyocardial fibrosis: Problems in differential diagnosis. Brit Heart J. 1976; 38::369–374.
    [Google Scholar]
78. Saraiva LR, Carneiro RW, Arruda MB, Brindeiro D and Lira V.  Mitral valve disease with rheumatic appearance in the presence of left ventricular endomyocardial fibrosis. Arq Bras Cardiol. 1999; 72::3, 330–332.
    [Google Scholar]
79. Chimenti C, Pieroni M and Frustaci A.  Endomyocardial fibrosis mimicking a dilated cardiomyopathy in a child. Heart. 2001; 86::1, 73.
    [Google Scholar]
80. Vaidyanathan K, Agarwal R, Sahayaraj A, Sankar M and Cherian KM.  Endomyocardial fibrosis mimicking Ebstein’s anomaly: a diagnostic challenge. Tex Heart Inst J. 2009; 36::3, 250–251.
    [Google Scholar]
81. Adebonojo SA and Jaiyesimi F.  Pericardio-peritoneal shunt for massive recurrent pericardial effusion in patients with endomyocardial fibrosis. Int Surg. 1977; 62::349–350.
    [Google Scholar]
82. Graham JM, Lawrie GM, Feteih NM and Debakey ME.  Management of endomyocardial fibrosis: Successful surgical treatment of biventricular involvement and consideration of the superiority of operative intervention. Am Heart J. 1981; 102::4, 771–775.
    [Google Scholar]
83. Schneider U, Jenni R, Turina J, Turina M and Hess OM.  Long term follow up of patients with endomyocardial fibrosis: effects of surgery. Heart. 1998; 79::362–367.
    [Google Scholar]
84. Dubost C, Chapelon C, Deloche A, Piette JC, Chauvaud S, Fabiani JN and Carpentier A.  Chirurgie des fibroses endomyocardiques: a propos de 32 cas. Arch mal Coeur. 1990; 83::481–486.
    [Google Scholar]
85. Moraes F, Lapa C, Hazin S, Tenorio E, Gomes C and Moraes CR.  Surgery of endomyocardial fibrosis revisited. Eur J Cardio-Thoracic Surg. 1999; 15::309–313.
    [Google Scholar]
86. Valiathan MS, Balakrishnan KG, Sankarkumar R and Kartha CC.  Surgical treatment of Endomyocardial Fibrosis. Ann Thorac Surg. 1987;43, 68–73.
    [Google Scholar]
87. Mocumbi AO, Sidi D, Vouhe P and Yacoub M.  An innovative technique for the relief of right ventricular trabecular cavity obliteration in endomyocardial fibrosis. J Thorac Cardiovasc Surg. 2007; 134::4, 1070–1072.
    [Google Scholar]
88. Joshi R, Abraham S and Kumar AS.  New approach for complete endocardiectomy in left ventricular endomyocardial fibrosis. J Thorac Cardiovasc Surg. 125::1, 40–42.
    [Google Scholar]
89. Yie K, Sung S, Kim D and Woo J.  Bidirectinal cavopulmonary shunt as a rescue procedure for right ventricular endomyocardial fibrosis. Interactive Cardiovascular and Thoracic Surgery. 2004; 3::86–88.
    [Google Scholar]
90. Anbarasu M, Krishna Manohar SR, Titus T and Neelakandhan KS.  One-an-a-half ventricle repair for right ventricular endomyocardial fibrosis. Asian Cardiovasc Thorac Ann. 2004; 12::4, 363–365.
    [Google Scholar]
91. Mishra A, Krisha Manohar SR, Sankar Kumar R and Valiathan MS.  Bidirectional Glenn shunt for right ventricular endomyocardial fibrosis. Asian Cardiovasc Thorac Ann. 2002; 10::4, 351–353.
    [Google Scholar]
92. Da Costa FDA, Moraes CR, Rodrigues JV, de Mendonca JT, Andrade JC, Buffolo E, Succi JE, Carvalho RG, Faraco DL and da Costa IA.  Early surgical results in the treatment of endomyocardial fibrosis. Eur J Cardio-Thorac Surg. 1989; 3::408–413.
    [Google Scholar]
93. Moraes CR, Buffolo E, Moraes Neto F, Rodrigues JV, Gomes CA, Branco JN and Aguiar L.  Recurrence of fibrosis after endomyocardial fibrosis surgery. Arq Bras Cardiol. 1996; 67::4, 297–299.
    [Google Scholar]
94. Freitas HFG, Castro PPN, Chizzola PR and Bocchi EA.  Transplante cardíaco em portadora de endomiocardiofibrose. Arq Bras Cardiol. 2005; 84::1, 49–50.
    [Google Scholar]
95. Mocumbi AO.  Echocardiography: a tool to foster research into neglected cardiovascular diseases in Africa. Int J Cardiovasc Imaging. 2011; 27::3, 321.
    [Google Scholar]